Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding Oyster Point Pharma, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 1 | 1 | 0 (0.0%) |
| Value | $11 | $11 | $0 (0.0%) |
New holders (0)
Institutions that held Oyster Point Pharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (0)
Institutions that held Oyster Point Pharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.